C3 and COVID-19: Therefore, the dysregulation in C3 and HBB serum protein levels observed in COVID-19 cohorts and previously reported in response to α-Gal51 may be due to gut microbiota dysbiosis associated to SARS-CoV-2 infection and COVID-19 severity (83, 84) (Supplementary Figure 8).